Table 1. PERMANOVA analysis of the tumour microbiome in Malaysian breast cancer patients
From: Characterization of intra-tumoral microbiota from transcriptomic sequencing of Asian breast cancer
 | df | SS | F | Pr(>F) | Total variance | Explained variance |
---|---|---|---|---|---|---|
Model | 12 | 0.87 | 1.03 | 0.391 | 27.69 | 0.031 |
PAM50 subtype | 4 | 0.31 | 1.12 | 0.283 | 27.69 | 0.011 |
Age at diagnosis | 1 | 0.085 | 1.21 | 0.227 | 27.69 | 0.0031 |
Ethnicity | 3 | 0.14 | 0.68 | 0.891 | 27.69 | 0.0052 |
Stage | 1 | 0.048 | 0.69 | 0.752 | 27.69 | 0.0017 |
Grade | 1 | 0.078 | 1.11 | 0.323 | 27.69 | 0.0028 |
Chemotherapy | 1 | 0.060 | 0.86 | 0.535 | 27.69 | 0.0022 |
IFNγ group | 1 | 0.17 | 2.43 | 0.015 | 27.69 | 0.0062 |
Residual | 382 | 26.83 | NA | NA | 27.69 | 0.97 |